Treg-targeting human monoclonal antibody (Surface Oncology)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameTreg-targeting human monoclonal antibody (Surface Oncology)
Drug Alias Nametumor microenvironment regulatory T-cells inhibitor (Surface Oncology)Treg modulator 2 (Surface Oncology)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionImmunostimulantsRegulatory T-lymphocytes inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSurface Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSurface Oncology Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A